A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults
Authors:
Posted in Papers / Human Studies|Original Research / October 16-31, 2025
Clin Pharmacol Drug Dev. 2025 Oct 19. doi: 10.1002/cpdd.1617. Online ahead of print.
PMID: 41109979 | DOI: 10.1002/cpdd.1617
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.